BioNTech/Pfizer Coronavirus vaccine 90 per cent effective in trials
The UK Health Secretary announced plans to roll out the new coronavirus vaccine, made by Pfizer and BioNTech, from as early as December 1, after preliminary trials showed 90 per cent effectiveness in patients.